Humana and Astellas Form Research Collaboration to Improve Health Care Delivery for Seniors
LOUISVILLE, Ky. & NORTHBROOK, Ill.--(BUSINESS WIRE)--
Humana
Inc. (NYSE: HUM), one of the nation’s leading health and well-being
companies, and Astellas Scientific and Medical Affairs Inc., a U.S.
subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today
announced a multi-year research collaboration to explore new ideas and
ways to improve the health and well-being of patients and members.
The two companies will bring together researchers and health care
experts from both companies to study key issues and develop ways to
reduce inefficiencies in the management of oncology, urology and
immunology conditions.
“This research collaboration will produce knowledge in important
therapeutic areas for our key population,” said William Fleming,
Pharm.D., President of Humana Pharmacy Solutions. “With about 77 percent1
of all cancers being diagnosed in people 55 years of age and older, and
1 in 22 males and 1 in 3 females at risk for developing
cancer in their lifetime, this partnership will serve to develop an
important body of knowledge that will meaningfully advance the work of
our respective companies.”
“We believe that the combination of Humana’s experience with affordable
senior health care and Astellas’ commitment to advancements in
healthcare, particularly in the areas of oncology, urology and
transplantation will help improve the lifelong well-being of patients,”
said Jeffrey Bloss, M.D., Vice President, Astellas Scientific and
Medical Affairs Inc. “Through this important collaboration, we’ll use
clinical data to conduct comparative effectiveness research to evaluate
ways to improve healthcare and health outcomes for patients.”
About Humana
Humana Inc., headquartered in Louisville, Ky., is a leading health care
company that offers a wide range of insurance products and health and
wellness services that incorporate an integrated approach to lifelong
well-being. By leveraging the strengths of its core businesses, Humana
believes it can better explore opportunities for existing and emerging
adjacencies in health care that can further enhance wellness
opportunities for the millions of people across the nation with whom the
company has relationships.
More information regarding Humana is available to investors via the
Investor Relations page of the company’s web site at www.humana.com,
including copies of:
Annual reports to stockholders
Securities and Exchange Commission filings
Most recent investor conference presentations
Quarterly earnings news releases
Replays of most recent earnings release conference calls
Calendar of events (including upcoming earnings conference call dates
and times, as well as planned interaction with research analysts and
institutional investors)
Corporate Governance information
About Astellas
Astellas Scientific and Medical Affairs Inc., located in Northbrook,
Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc.
Astellas is a pharmaceutical company dedicated to improving the health
of people around the world through the provision of innovative and
reliable pharmaceutical products. The organization is committed to
becoming a global category leader in focused areas by combining
outstanding R&D and marketing capabilities. For more information about
Astellas, please visit our website at www.astellas.us.
Press Release $HUM Humana Inc.
LOUISVILLE, Ky. & NORTHBROOK, Ill.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, and Astellas Scientific and Medical Affairs Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced a multi-year research collaboration to explore new ideas and ways to improve the health and well-being of patients and members.
The two companies will bring together researchers and health care experts from both companies to study key issues and develop ways to reduce inefficiencies in the management of oncology, urology and immunology conditions.
“This research collaboration will produce knowledge in important therapeutic areas for our key population,” said William Fleming, Pharm.D., President of Humana Pharmacy Solutions. “With about 77 percent1 of all cancers being diagnosed in people 55 years of age and older, and 1 in 22 males and 1 in 3 females at risk for developing cancer in their lifetime, this partnership will serve to develop an important body of knowledge that will meaningfully advance the work of our respective companies.”
“We believe that the combination of Humana’s experience with affordable senior health care and Astellas’ commitment to advancements in healthcare, particularly in the areas of oncology, urology and transplantation will help improve the lifelong well-being of patients,” said Jeffrey Bloss, M.D., Vice President, Astellas Scientific and Medical Affairs Inc. “Through this important collaboration, we’ll use clinical data to conduct comparative effectiveness research to evaluate ways to improve healthcare and health outcomes for patients.”
About Humana
Humana Inc., headquartered in Louisville, Ky., is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
About Astellas
Astellas Scientific and Medical Affairs Inc., located in Northbrook, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. For more information about Astellas, please visit our website at www.astellas.us.
1 http://www.cancer.org/acs/groups/content/@corporatecommunications/documents/document/acspc-034356.pdf
2 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
Humana Corporate Communications
Alex Kepnes, 502-580-2990
akepnes@humana.com
or
Astellas Corporate Communications
Jenny Kite, 224-205-5405
jenny.kite@astellas.com
Source: Humana Inc.